| CPC G01Q 20/02 (2013.01) [C12N 9/22 (2013.01); C12N 15/11 (2013.01); C12Q 1/683 (2013.01); G01Q 60/42 (2013.01); C12N 2310/20 (2017.05); C12N 2800/80 (2013.01); C12Q 2565/601 (2013.01)] | 26 Claims |
|
1. A method of mapping nucleotide molecules, comprising:
incubating a target nucleotide in a magnesium-free mixture, wherein the magnesium-free mixture comprises a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-cellular apoptosis susceptibility (Cas) protein and a guide ribonucleic acid (RNA), and wherein incubating the target nucleotide with the CRISPR-Cas protein binds the CRISPR-Cas protein to the target nucleotide to form a CRISPR-Cas/target nucleotide complex without the CRISPR-Cas protein cleaving the target nucleotide;
depositing the CRISPR-Cas/target nucleotide complex on a flat surface, wherein after deposition the CRISPR-Cas/target nucleotide complex is bound to the flat surface; and
imaging the CRISPR-Cas/target nucleotide complex on the flat surface by using high-speed atomic force microscopy (AFM) operating in contact mode, wherein the high speed AFM has a probe linear speed of 4 to 10 millimeters per second, wherein the high-speed atomic force microscopy comprises an AFM system which comprises: at least one cantilever; at least one scanning probe arrangement including a laser positioned over a portion of the at least one cantilever which contacts a surface of at least one sample, wherein a tilt angle of the at least one cantilever with respect to the at least one scanning probe arrangement is less than 10 degrees; and a power source configured to generate a displacement noise that is less than 300 Picometers.
|